Read + Share
Kim DK, Synn CB, Lee W, Jo HN, et al. Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding
Potent Anticancer Effects by Combination with Pembrolizumab. Mol Cancer Ther 2025;24:354-369.
PMID: 39632711
|
 |
|
Kim DK, Synn CB, Lee W, Jo HN, et al. Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding
Potent Anticancer Effects by Combination with Pembrolizumab. Mol Cancer Ther 2025;24:354-369.
PMID: 39632711
|
|
|
|